S&P 500
(-0.16%) 5 460.56 points
Dow Jones
(-0.12%) 39 067 points
Nasdaq
(0.08%) 17 732 points
Oil
(-0.15%) $80.71
Gas
(-3.70%) $2.65
Gold
(-0.71%) $2 314.20
Silver
(0.15%) $28.91
Platinum
(1.99%) $1 006.00
USD/EUR
(0.30%) $0.936
USD/NOK
(0.77%) $10.69
USD/GBP
(0.49%) $0.792
USD/RUB
(0.00%) $87.49

के लिए वास्तविक समय के अद्यतन Infinity Pharmaceuticals [INFI]

एक्सचेंज: NASDAQ क्षेत्र: Healthcare उद्योग: Biotechnology
अंतिम अद्यतन30 Sep 2023 @ 01:29

-52.38% $ 0.00800

Live Chart Being Loaded With Signals

Commentary (30 Sep 2023 @ 01:29):
Profile picture for Infinity Pharmaceuticals Inc

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors...

Stats
आज की मात्रा 2.48M
औसत मात्रा 3.98M
बाजार मूल्य 726 089
EPS $-0.110 ( Q2 | 2023-08-10 )
अगली कमाई की तारीख ( $0 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0182
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00900 (230.77%)
AADI -2.94%
ABCL 1.65%
ABCM 0.04%
ABEO -2.84%
ABIO -1.68%
ABOS 1.64%
ABSI 2.89%
ABUS -2.30%
ABVX -3.53%
ACAD -0.71%
ACER -17.95%
ACET -4.09%
ACGN 1.29%
ACHL -3.00%
ACHV -1.61%
ACIU -1.00%
ACLX 0.13%
ACRV -4.79%
ACST -1.63%
ACXP 0.65%
ADAG 4.64%
ADAP -2.91%
ADGI 0.87%
ADIL 0.54%
ADMA -2.68%
ADPT -0.30%
ADTX -3.47%
ADVM -3.91%
ADXN -1.60%
AEON -3.74%
AEZS -3.51%
AFMD -1.40%
AGEN -1.82%
AGIO -2.06%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -3.46%
AKRO -2.89%
AKTX 4.08%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -2.29%
ALGS -2.41%
ALKS -0.21%
ALLK -9.32%
ALLO -6.05%
ALLR -3.22%
ALNA 3.16%
ALNY 1.81%
ALPN 0.02%
ALPX 0.00%
ALRN -0.33%
ALT -9.65%
ALVR -0.56%
ALXN 0.00%
ALXO -10.96%
ALZN 4.78%
AMRN -0.31%
AMTI -3.13%
ANAB 0.46%
ANEB -1.52%
ANGN 0.00%
ANIX -1.62%
ANL -6.60%
ANNX -0.66%
ANPC -3.15%
APGE -0.91%
APGN 8.48%
APGNW 30.65%
APLM 1.56%
APLS 0.09%
APLT -5.41%
APM -1.47%
APOP 0.38%
APRE 2.29%
APTO 3.27%
APTX 3.17%
APVO 0.18%
ARAV -13.39%
ARCT -3.90%
ARDS -14.23%
ARDX -0.58%
ARGX -0.73%
ARNA 0.00%
ARPO -0.90%
ARQT -0.52%
ARTL -2.50%
ARTLW 0.00%
ARVN 5.64%
ARWR -1.67%
ASLN -5.04%
ASMB -7.14%
ASND -0.94%
ATAI -1.48%
ATHA 5.94%
ATHE 1.12%
ATHX -33.50%
ATNF 0.99%
ATOS 2.91%
ATRA -2.21%
ATXI 1.93%
ATXS -1.00%
AUPH -1.17%
AURA 1.17%
AUTL -1.72%
AVBP -2.86%
AVEO 0.00%
AVIR -0.15%
AVRO -1.41%
AVTE -5.48%
AVTX -1.25%
AVXL -2.72%
AXLA 0.00%
AXSM -1.99%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.96%
BCAB 2.30%
BCDA -2.07%
BCDAW -41.77%
BCEL 0.00%
BCLI 7.14%
BCRX 1.32%
BCTX 7.65%
BCTXW -16.32%
BCYC 1.10%
BDRX -3.52%
BDTX -0.43%
BEAM 0.49%
BFRA -2.91%
BGNE -2.72%
BIOR -3.40%
BIVI 2.05%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.85%
BLTE -0.62%
BLU 0.03%
BLUE -0.71%
BMEA -9.88%
BMRN 0.38%
BNOX -2.22%
BNTC -2.11%
BNTX -1.47%
BOLD -8.11%
BOLT 1.31%
BPMC -1.27%
BPTH 1.86%
BPTS -13.47%
BRNS -0.74%
BRTX -2.36%
BTAI 22.88%
BTTX 53.33%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 3.39%
CABA 0.62%
CADL -1.05%
CALA 0.00%
CALC -1.77%
CALT -0.59%
CAPR -2.80%
CARA 0.21%
CARM 12.17%
CASI -1.67%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -6.89%
CCCC -5.30%
CCXI 0.00%
CDAK 0.00%
CDIO -2.02%
CDIOW 24.00%
CDMO -2.82%
CDMOP 0.04%
CDT -10.57%
CDTTW -39.60%
CDTX -1.92%
CDXC 0.00%
CDXS 6.07%
CELC -4.25%
CELU -1.50%
CELUW 11.80%
CERC -1.68%
CERE -0.96%
CERO -4.50%
CEROW -10.18%
CFRX -27.95%
CGEM -2.62%
CGEN -3.31%
CGON -0.54%
CGTX -5.11%
CHMA -6.00%
CHRS -0.63%
CINC 0.00%
CING 2.56%
CINGW 34.95%
CKPT -2.87%
CLBS -16.75%
CLDX -2.32%
CLGN 0.34%
CLLS -4.15%
CLNN 2.42%
CLNNW 0.00%
CLRB 7.04%
CLSD 1.02%
CLSN -0.68%
CLVS 0.00%
CMMB -0.01%
CMND 3.63%
CMPI 0.00%
CMPX -7.50%
CMRA 0.00%
CMRAW 33.33%
CMRX -2.71%
CNCE 0.00%
CNSP -39.08%
CNST 0.00%
CNTA -0.67%
CNTB -2.25%
CNTX -6.85%
COCP -2.02%
COEPW 32.45%
COGT -2.82%
CORT 2.20%
COYA -1.46%
CPRX -0.99%
CRBP -1.88%
CRBU -4.83%
CRDF -1.77%
CRGX 1.28%
CRIS -0.38%
CRNX -5.81%
CRSP 0.93%
CRTX 2.63%
CRVO -2.50%
CRVS 1.12%
CSBR -1.59%
CTCX -1.63%
CTIC 0.06%
CTMX -3.31%
CTNM -0.65%
CTXR 2.03%
CUE 3.53%
CVAC -2.26%
CVKD -5.23%
CWBR 2.80%
CYAD -12.96%
CYCC 10.09%
CYCCP 5.49%
CYCN 0.43%
CYT -2.27%
CYTK -2.08%
CYTO -2.73%
DARE 6.41%
DAWN 0.52%
DBTX -0.81%
DBVT 4.44%
DFFN 10.28%
DICE 0.06%
DMAC 30.75%
DNLI -1.43%
DNTH -6.31%
DOMH -1.58%
DRMA -1.10%
DRMAW -1.25%
DRNA 0.00%
DRTS 1.85%
DRTSW 0.00%
DRUG 0.95%
DSGN -1.21%
DTIL 1.36%
DYAI 9.68%
EARS -1.77%
EDIT -2.52%
EDSA -1.00%
EFTR 8.18%
EFTRW -51.85%
EIGR -9.21%
ELAB -1.00%
ELDN 7.98%
ELEV -4.98%
ELOX 7.69%
ELTX -0.88%
ELVN -4.05%
ELYM 1.05%
ENGN 1.67%
ENGNW 0.12%
ENLV 2.54%
ENOB 1.79%
ENSC 4.13%
ENTA -0.49%
ENTO -4.42%
ENTX 0.69%
ENVB 1.10%
EPIX -0.10%
EPRX -2.97%
EPZM 0.00%
EQ 0.86%
EQRX -2.09%
EQRXW 0.00%
ERAS -1.20%
ERNA 0.00%
ERYP 1.30%
ESLA 4.30%
ESLAW 87.05%
ETNB -1.02%
ETON 1.68%
ETTX 0.00%
EVAX -2.14%
EVGN 3.88%
EVLO 0.00%
EWTX 0.00%
EXAI -0.57%
EXEL -0.36%
EYEG -0.69%
EYEN 1.48%
EYPT -0.24%
FATE -7.80%
FBIO 0.59%
FBIOP 0.92%
FBLG -14.30%
FBRX -0.04%
FDMT -4.82%
FENC -0.97%
FGEN -5.56%
FHTX 2.10%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.58%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.31%
FULC -3.34%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -6.28%
GANX -1.49%
GBIO -2.12%
GBT 0.01%
GDTC 0.50%
GERN -4.31%
GHRS -1.59%
GLMD -2.32%
GLPG -2.26%
GLSI 2.80%
GLTO -0.57%
GLUE -2.36%
GLYC -10.00%
GMAB -0.43%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -2.92%
GNLX 1.33%
GNPX 0.00%
GNTA 3.94%
GOSS -9.46%
GOVX 7.27%
GOVXW -49.04%
GPCR -6.48%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -0.08%
GRTX 0.00%
GTHX 0.68%
GUTS -5.31%
GXGXW 41.67%
GYRE -7.16%
HALO -1.15%
HARP 0.09%
HCWB -3.75%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -0.38%
HOOK 0.80%
HOTH -2.70%
HOWL -2.14%
HRMY 0.85%
HRTX 2.46%
HSTO 0.00%
HUMA 1.32%
HUMAW -0.01%
IBRX -3.85%
ICCC 0.22%
ICPT 0.21%
ICU 16.49%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.94%
IFRX -1.85%
IGMS -0.15%
IKNA 0.30%
IKT 1.42%
IMAB -0.58%
IMCR -2.61%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -6.90%
IMNM -1.65%
IMNN 0.88%
IMPL -27.27%
IMRA 15.96%
IMRN -1.18%
IMRX 0.00%
IMTX -1.58%
IMTXW 6.00%
IMUX 1.56%
IMV 0.00%
IMVT -3.68%
INAB 0.00%
INBX 0.53%
INCY -0.86%
INDP 11.07%
INFI -52.38%
INKT -0.01%
INM -2.20%
INMB 3.01%
INO -2.21%
INSM -0.85%
INTS -2.75%
INVA 0.22%
INZY 0.92%
IOBT -11.42%
IONS 0.34%
IOVA -2.31%
IPA 2.46%
IPHA 5.58%
IPSC -2.15%
IRON -2.54%
ISEE 0.38%
ITOS -1.50%
ITRM 1.67%
IVA 6.96%
IVVD -3.72%
JAGX 1.05%
JANX -4.03%
JAZZ -0.74%
JNCE 0.00%
JSPR -6.10%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -3.94%
KALV -1.95%
KDNY 0.22%
KMPH -0.34%
KNSA -2.85%
KNTE -0.38%
KOD -7.11%
KPRX 0.96%
KPTI -1.38%
KRBP -10.00%
KRON 1.05%
KROS -1.20%
KRRO -6.34%
KRTX 0.03%
KRYS -0.90%
KTRA 18.45%
KTTA 8.16%
KTTAW 0.92%
KURA -1.83%
KYMR -2.41%
KYTX -4.46%
KZIA 5.16%
KZR -1.49%
LABP 0.57%
LBPH -1.71%
LBPS 0.00%
LBPSW 14.81%
LEGN 1.65%
LENZ -3.36%
LEXX 0.00%
LEXXW -14.63%
LGND -1.30%
LGNDV 0.00%
LGVN -9.61%
LIAN -8.28%
LIFE 2.70%
LIPO -7.10%
LIXT -5.24%
LIXTW 63.57%
LJPC -0.32%
LMNL 0.12%
LOGC 0.61%
LPCN -4.05%
LPTX -1.10%
LQDA -0.33%
LRMR -1.92%
LSTA -4.06%
LTRN 1.76%
LUMO -1.32%
LVTX 0.00%
LXEO -4.33%
LXRX -2.06%
LYEL -34.47%
LYRA 2.33%
MACK 0.10%
MBIO -9.32%
MBRX -1.72%
MCRB 1.76%
MDGL -2.70%
MDNA -13.16%
MDWD 0.10%
MDXG -2.58%
MEIP -0.13%
MESO -1.78%
MGNX -3.03%
MGTA -7.74%
MGTX -2.97%
MGX -2.68%
MIRM -1.80%
MIRO 0.59%
MIST 1.54%
MITO 0.00%
MLEC -7.69%
MLECW 2.31%
MLND -5.36%
MLTX -0.63%
MLYS -5.79%
MNKD -1.15%
MNMD 0.21%
MNOV 2.11%
MNPR -5.01%
MOLN 0.28%
MOR 1.18%
MORF -3.86%
MREO -5.29%
MRKR 2.68%
MRNA -4.81%
MRNS -4.04%
MRSN -2.61%
MRTX -0.17%
MRUS 0.13%
MRVI -1.82%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -1.24%
MYMD 8.38%
NAMS 1.37%
NAMSW 0.43%
NAUT 1.15%
NBRV 0.71%
NBSE -1.56%
NBTX 8.61%
NCNA 1.09%
NERV -1.90%
NEXI 2.60%
NGM -1.28%
NGNE -2.03%
NKGN 6.78%
NKGNW 8.00%
NKTR -4.21%
NKTX -4.57%
NLSP -2.82%
NLSPW 26.67%
NMRA -1.32%
NMTR -42.97%
NOVN -24.84%
NRBO 11.11%
NRIX -0.34%
NRSN -7.05%
NRSNW 0.00%
NRXP -4.09%
NRXPW 18.33%
NRXS 4.82%
NTBL 5.06%
NTEC -12.45%
NTHI 0.00%
NTLA -6.13%
NTRBW -31.07%
NUVL -2.00%
NVAX -2.22%
NVCT 3.59%
NVIV -34.28%
NXTC -2.94%
NYMX -0.05%
OABI 0.26%
OABIW -10.06%
OBIO -2.48%
OBSV 0.00%
OCEA 0.00%
OCGN 3.81%
OCS -1.02%
OCUL -2.21%
OCUP 1.96%
ODT -4.27%
OKYO 1.51%
OLMA -5.29%
OMER -1.28%
OMGA 5.00%
ONCO 5.04%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY 0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 3.09%
ORGS -2.07%
ORIC -3.56%
ORMP 15.09%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.81%
OVID -1.44%
OYST 0.00%
PALI -0.87%
PASG -1.30%
PBLA -7.50%
PBM -6.75%
PBYI 1.69%
PCSA 0.00%
PCVX -0.28%
PDSB -2.52%
PEPG 0.27%
PGEN -3.04%
PHAR 1.51%
PHAS 0.00%
PHAT -1.06%
PHIO -3.57%
PHIOW 36.47%
PHVS -7.22%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -1.10%
PLUR 6.01%
PMN 0.72%
PMVP -1.19%
PNT 0.16%
PPBT -4.26%
PRAX 0.63%
PRDS 0.93%
PRLD 0.00%
PROG -3.47%
PROK 0.00%
PRQR -0.01%
PRTA -2.65%
PRTC 0.49%
PRTG -0.50%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -5.11%
PSTX -0.97%
PTCT -0.28%
PTE -0.82%
PTGX -1.76%
PTIXW -49.04%
PULM 2.60%
PXMD 0.00%
PYPD 0.07%
PYXS 1.96%
QLGN -3.72%
QNCX 5.70%
QNRX 0.37%
QSI -11.97%
QSIAW -3.13%
QTTB -4.54%
QURE -0.22%
RAIN -1.63%
RANI 6.42%
RAPT -2.92%
RARE 1.41%
RCKT -7.76%
REGN -0.70%
RENB -3.42%
REPL -2.61%
RETA 0.02%
REUN -0.89%
REVB -1.40%
REVBU 3.46%
REVBW 4.38%
RGLS -4.91%
RGNX -5.44%
RIGL -3.29%
RLAY -4.67%
RLMD 0.33%
RLYB 0.00%
RNA -0.49%
RNAC -5.65%
RNAZ -0.96%
RNXT 1.88%
ROIV -2.08%
ROIVW 4.56%
RPHM 0.00%
RPRX -0.07%
RPTX -2.93%
RUBY 2.70%
RVLP -32.05%
RVMD -1.20%
RVMDW -30.00%
RVNC 2.34%
RVPH -1.58%
RVPHW 1.62%
RXDX 0.09%
RXRX -3.46%
RYTM -6.51%
RYZB 0.02%
RZLT 1.68%
SABS -1.37%
SABSW -11.81%
SAGE 1.56%
SANA -4.06%
SAVA -0.31%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 5.50%
SCPH 0.00%
SCPS 0.00%
SEEL -4.48%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -1.03%
SGMT -1.69%
SGTX -2.56%
SIOX 22.63%
SLDB -7.07%
SLGL 4.00%
SLN -4.21%
SLNO -4.03%
SLRX 6.04%
SLS -2.58%
SMMT -3.00%
SNDX 0.87%
SNGX -4.52%
SNPX -0.81%
SONN -1.08%
SPPI -0.49%
SPRB 0.32%
SPRC -4.17%
SPRO 0.30%
SRNE -34.00%
SRPT -1.44%
SRRA 0.00%
SRRK -2.79%
SRZN -2.45%
STAB 0.00%
STOK -5.09%
STRO -2.84%
STSA 0.00%
STTK -4.78%
SURF -0.93%
SVRA -3.29%
SWTX 0.34%
SYBX -1.94%
SYRS -1.72%
TALS -0.73%
TARA -7.57%
TARS -0.23%
TBPH 0.60%
TCBP 2.73%
TCDA 0.00%
TCON -2.03%
TCRR 0.00%
TCRT 1.59%
TCRX 2.58%
TECH -0.14%
TENX -1.27%
TERN -7.72%
TFFP -3.05%
TGTX -2.97%
THRX 0.12%
TIL -0.20%
TLC 0.00%
TLSA -3.09%
TNGX -2.16%
TNXP -6.39%
TNYA -7.02%
TPST 2.87%
TRDA -3.93%
TRVI 1.15%
TRVN 2.92%
TSHA -24.34%
TSVT -2.79%
TTNP -9.27%
TVTX 0.63%
TYRA -7.01%
UBX -2.12%
UNCY -2.43%
URGN -1.00%
UTHR -0.39%
VACC 11.36%
VALN -2.89%
VAXX 84.85%
VBIV 0.78%
VBLT -8.77%
VCEL 0.09%
VCNX 10.35%
VCYT -1.23%
VERA -2.74%
VERU 0.79%
VERV -2.96%
VIGL 5.11%
VINC 1.62%
VIR 0.54%
VIRI -1.57%
VIRX 2.40%
VKTX -1.67%
VLON -13.04%
VNDA -2.20%
VOR -2.02%
VRCA -0.07%
VRDN -4.31%
VRNA -1.40%
VRPX 0.38%
VRTX 0.39%
VSTM -3.74%
VTGN -0.45%
VTVT -2.97%
VTYX -0.21%
VXRT -2.90%
VYGR -1.53%
VYNE -3.47%
VYNT 7.78%
WINT -3.24%
WVE -4.51%
XBIO 0.93%
XBIT 1.77%
XCUR 3.58%
XENE -2.85%
XERS 2.38%
XFOR 2.62%
XLO 2.00%
XLRN 0.00%
XNCR 0.47%
XOMA -3.57%
XOMAO 0.36%
XOMAP -0.82%
XRTX -8.92%
YMAB -1.80%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -3.51%
ZNTL -2.38%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-09-09 Perkins Adelene Q Buy 768 133 Common Stock
2023-09-12 Perkins Adelene Q Sell 410 196 Common Stock
2023-09-09 Perkins Adelene Q Sell 768 133 Restricted Stock Unit
2022-08-02 Peluso Stephane Buy 14 994 Common Stock
2022-08-02 Peluso Stephane Sell 50 000 Restricted Stock Unit
INSIDER POWER
-20.62
Last 96 transactions
Buy: 10 433 668 | Sell: 9 549 867

मात्रा सहसंबंध

लंबा: 0.01 (neutral)
छोटा: 0.15 (neutral)
Signal:(27.787) Neutral

Infinity Pharmaceuticals सहसंबंध

10 सबसे अधिक सकारात्मक सहसंबंध
CHNA0.856
10 सबसे अधिक नकारात्मक सहसंबंध
HPLT-0.889

क्या आप जानते हैं?

कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।

कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।

Infinity Pharmaceuticals सहसंबंध - मुद्रा/वस्त्र

The country flag -0.53
( weak negative )
The country flag -0.01
( neutral )
The country flag 0.00
( neutral )
The country flag -0.42
( neutral )
The country flag 0.00
( neutral )
The country flag 0.84
( strong )

Infinity Pharmaceuticals वित्तीय

Annual 2022
राजस्व: $2.59M
सकल लाभ: $1.03M (39.72 %)
EPS: $-0.480
FY 2022
राजस्व: $2.59M
सकल लाभ: $1.03M (39.72 %)
EPS: $-0.480
FY 2021
राजस्व: $1.86M
सकल लाभ: $738 000 (39.72 %)
EPS: $-0.530
FY 2020
राजस्व: $1.72M
सकल लाभ: $682 000 (39.67 %)
EPS: $-0.680

Financial Reports:

No articles found.

Infinity Pharmaceuticals Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Infinity Pharmaceuticals

Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of metastatic triple negative breast cancer and urothelial cancer; and Phase 1/1b clinical trials for the treatment of solid tumors. The company has strategic alliances with Intellikine, Inc. to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K; Verastem, Inc. to research, develop, commercialize, and manufacture duvelisib and products containing duvelisib; and PellePharm, Inc. to develop and commercialize rights to its hedgehog inhibitor program, IPI-926, a clinical-stage product candidate, as well as collaboration agreements with Arcus Biosciences, Inc., F. Hoffmann-La Roche Ltd., and Bristol Myers Squibb Company. Infinity Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in Cambridge, Massachusetts.

के बारे में लाइव सिग्नल्स

इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।

लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं

Total Execution Time: 2.8618130683899 seconds
Number of API calls: 3
Number of DB calls: 9